nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicyclomine—CYP1A1—Cholecalciferol—osteoporosis	0.225	0.554	CbGbCtD
Dicyclomine—CYP1A1—Estradiol—osteoporosis	0.181	0.446	CbGbCtD
Dicyclomine—Urticaria—Estropipate—osteoporosis	0.00101	0.00171	CcSEcCtD
Dicyclomine—Vision blurred—Zoledronate—osteoporosis	0.001	0.00171	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Raloxifene—osteoporosis	0.001	0.0017	CcSEcCtD
Dicyclomine—Abdominal pain—Estropipate—osteoporosis	0.001	0.0017	CcSEcCtD
Dicyclomine—Feeling abnormal—Ibandronate—osteoporosis	0.001	0.0017	CcSEcCtD
Dicyclomine—Nervousness—Conjugated Estrogens—osteoporosis	0.000997	0.00169	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Ibandronate—osteoporosis	0.000994	0.00169	CcSEcCtD
Dicyclomine—Urticaria—Alendronate—osteoporosis	0.000992	0.00168	CcSEcCtD
Dicyclomine—Ill-defined disorder—Zoledronate—osteoporosis	0.000989	0.00168	CcSEcCtD
Dicyclomine—Abdominal pain—Alendronate—osteoporosis	0.000987	0.00168	CcSEcCtD
Dicyclomine—Shock—Risedronate—osteoporosis	0.000985	0.00167	CcSEcCtD
Dicyclomine—Nervous system disorder—Risedronate—osteoporosis	0.000982	0.00167	CcSEcCtD
Dicyclomine—Discomfort—Pamidronate—osteoporosis	0.000981	0.00167	CcSEcCtD
Dicyclomine—Agitation—Zoledronate—osteoporosis	0.000979	0.00166	CcSEcCtD
Dicyclomine—Angioedema—Zoledronate—osteoporosis	0.000974	0.00165	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Calcitriol—osteoporosis	0.000973	0.00165	CcSEcCtD
Dicyclomine—Abdominal pain—Raloxifene—osteoporosis	0.000971	0.00165	CcSEcCtD
Dicyclomine—Vision blurred—Conjugated Estrogens—osteoporosis	0.000967	0.00164	CcSEcCtD
Dicyclomine—Urticaria—Ibandronate—osteoporosis	0.000966	0.00164	CcSEcCtD
Dicyclomine—Malaise—Zoledronate—osteoporosis	0.000961	0.00163	CcSEcCtD
Dicyclomine—Abdominal pain—Ibandronate—osteoporosis	0.000961	0.00163	CcSEcCtD
Dicyclomine—Confusional state—Pamidronate—osteoporosis	0.00096	0.00163	CcSEcCtD
Dicyclomine—Syncope—Zoledronate—osteoporosis	0.000956	0.00162	CcSEcCtD
Dicyclomine—Oedema—Pamidronate—osteoporosis	0.000952	0.00162	CcSEcCtD
Dicyclomine—Anaphylactic shock—Pamidronate—osteoporosis	0.000952	0.00162	CcSEcCtD
Dicyclomine—Urticaria—Calcitriol—osteoporosis	0.000945	0.0016	CcSEcCtD
Dicyclomine—Palpitations—Zoledronate—osteoporosis	0.000942	0.0016	CcSEcCtD
Dicyclomine—Abdominal pain—Calcitriol—osteoporosis	0.000941	0.0016	CcSEcCtD
Dicyclomine—Hypoaesthesia—Estradiol—osteoporosis	0.000939	0.00159	CcSEcCtD
Dicyclomine—Angioedema—Conjugated Estrogens—osteoporosis	0.000938	0.00159	CcSEcCtD
Dicyclomine—Shock—Pamidronate—osteoporosis	0.000937	0.00159	CcSEcCtD
Dicyclomine—Loss of consciousness—Zoledronate—osteoporosis	0.000937	0.00159	CcSEcCtD
Dicyclomine—Hypersensitivity—Estropipate—osteoporosis	0.000934	0.00159	CcSEcCtD
Dicyclomine—Nervous system disorder—Pamidronate—osteoporosis	0.000934	0.00159	CcSEcCtD
Dicyclomine—Vomiting—Etidronic acid—osteoporosis	0.000931	0.00158	CcSEcCtD
Dicyclomine—Tachycardia—Pamidronate—osteoporosis	0.000929	0.00158	CcSEcCtD
Dicyclomine—Rash—Etidronic acid—osteoporosis	0.000924	0.00157	CcSEcCtD
Dicyclomine—Dermatitis—Etidronic acid—osteoporosis	0.000923	0.00157	CcSEcCtD
Dicyclomine—Syncope—Conjugated Estrogens—osteoporosis	0.00092	0.00156	CcSEcCtD
Dicyclomine—Hypertension—Zoledronate—osteoporosis	0.00092	0.00156	CcSEcCtD
Dicyclomine—Hypersensitivity—Alendronate—osteoporosis	0.00092	0.00156	CcSEcCtD
Dicyclomine—Headache—Etidronic acid—osteoporosis	0.000918	0.00156	CcSEcCtD
Dicyclomine—Asthenia—Estropipate—osteoporosis	0.000909	0.00154	CcSEcCtD
Dicyclomine—Anorexia—Pamidronate—osteoporosis	0.000908	0.00154	CcSEcCtD
Dicyclomine—Palpitations—Conjugated Estrogens—osteoporosis	0.000907	0.00154	CcSEcCtD
Dicyclomine—Insomnia—Risedronate—osteoporosis	0.000906	0.00154	CcSEcCtD
Dicyclomine—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000902	0.00153	CcSEcCtD
Dicyclomine—Paraesthesia—Risedronate—osteoporosis	0.000899	0.00153	CcSEcCtD
Dicyclomine—Pruritus—Estropipate—osteoporosis	0.000897	0.00152	CcSEcCtD
Dicyclomine—Discomfort—Zoledronate—osteoporosis	0.000896	0.00152	CcSEcCtD
Dicyclomine—Asthenia—Alendronate—osteoporosis	0.000896	0.00152	CcSEcCtD
Dicyclomine—Hypersensitivity—Ibandronate—osteoporosis	0.000895	0.00152	CcSEcCtD
Dicyclomine—Dyspnoea—Risedronate—osteoporosis	0.000893	0.00152	CcSEcCtD
Dicyclomine—Dry mouth—Zoledronate—osteoporosis	0.000887	0.00151	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000887	0.00151	CcSEcCtD
Dicyclomine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000886	0.0015	CcSEcCtD
Dicyclomine—Pruritus—Alendronate—osteoporosis	0.000883	0.0015	CcSEcCtD
Dicyclomine—Dyspepsia—Risedronate—osteoporosis	0.000882	0.0015	CcSEcCtD
Dicyclomine—Eye disorder—Estradiol—osteoporosis	0.000882	0.0015	CcSEcCtD
Dicyclomine—Constipation—Ethinyl Estradiol—osteoporosis	0.000879	0.00149	CcSEcCtD
Dicyclomine—Confusional state—Zoledronate—osteoporosis	0.000877	0.00149	CcSEcCtD
Dicyclomine—Hypersensitivity—Calcitriol—osteoporosis	0.000877	0.00149	CcSEcCtD
Dicyclomine—Cardiac disorder—Estradiol—osteoporosis	0.000876	0.00149	CcSEcCtD
Dicyclomine—Asthenia—Ibandronate—osteoporosis	0.000872	0.00148	CcSEcCtD
Dicyclomine—Nausea—Etidronic acid—osteoporosis	0.00087	0.00148	CcSEcCtD
Dicyclomine—Oedema—Zoledronate—osteoporosis	0.00087	0.00148	CcSEcCtD
Dicyclomine—Anaphylactic shock—Zoledronate—osteoporosis	0.00087	0.00148	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Risedronate—osteoporosis	0.000865	0.00147	CcSEcCtD
Dicyclomine—Fatigue—Risedronate—osteoporosis	0.000864	0.00147	CcSEcCtD
Dicyclomine—Insomnia—Pamidronate—osteoporosis	0.000861	0.00146	CcSEcCtD
Dicyclomine—Pruritus—Ibandronate—osteoporosis	0.00086	0.00146	CcSEcCtD
Dicyclomine—Pain—Risedronate—osteoporosis	0.000857	0.00145	CcSEcCtD
Dicyclomine—Constipation—Risedronate—osteoporosis	0.000857	0.00145	CcSEcCtD
Dicyclomine—Shock—Zoledronate—osteoporosis	0.000856	0.00145	CcSEcCtD
Dicyclomine—Paraesthesia—Pamidronate—osteoporosis	0.000855	0.00145	CcSEcCtD
Dicyclomine—Asthenia—Calcitriol—osteoporosis	0.000854	0.00145	CcSEcCtD
Dicyclomine—Nervous system disorder—Zoledronate—osteoporosis	0.000853	0.00145	CcSEcCtD
Dicyclomine—Immune system disorder—Estradiol—osteoporosis	0.000852	0.00145	CcSEcCtD
Dicyclomine—Mediastinal disorder—Estradiol—osteoporosis	0.00085	0.00144	CcSEcCtD
Dicyclomine—Dyspnoea—Pamidronate—osteoporosis	0.000849	0.00144	CcSEcCtD
Dicyclomine—Tachycardia—Zoledronate—osteoporosis	0.000849	0.00144	CcSEcCtD
Dicyclomine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000847	0.00144	CcSEcCtD
Dicyclomine—Somnolence—Pamidronate—osteoporosis	0.000846	0.00144	CcSEcCtD
Dicyclomine—Pruritus—Calcitriol—osteoporosis	0.000842	0.00143	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00084	0.00143	CcSEcCtD
Dicyclomine—Dyspepsia—Pamidronate—osteoporosis	0.000838	0.00142	CcSEcCtD
Dicyclomine—Dizziness—Estropipate—osteoporosis	0.000838	0.00142	CcSEcCtD
Dicyclomine—Oedema—Conjugated Estrogens—osteoporosis	0.000837	0.00142	CcSEcCtD
Dicyclomine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000837	0.00142	CcSEcCtD
Dicyclomine—Anorexia—Zoledronate—osteoporosis	0.000829	0.00141	CcSEcCtD
Dicyclomine—Decreased appetite—Pamidronate—osteoporosis	0.000828	0.00141	CcSEcCtD
Dicyclomine—Mental disorder—Estradiol—osteoporosis	0.000827	0.0014	CcSEcCtD
Dicyclomine—Dizziness—Alendronate—osteoporosis	0.000825	0.0014	CcSEcCtD
Dicyclomine—Shock—Conjugated Estrogens—osteoporosis	0.000824	0.0014	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000822	0.0014	CcSEcCtD
Dicyclomine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000821	0.00139	CcSEcCtD
Dicyclomine—Erythema—Estradiol—osteoporosis	0.000821	0.00139	CcSEcCtD
Dicyclomine—Fatigue—Pamidronate—osteoporosis	0.000821	0.00139	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Risedronate—osteoporosis	0.000819	0.00139	CcSEcCtD
Dicyclomine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000817	0.00139	CcSEcCtD
Dicyclomine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000816	0.00139	CcSEcCtD
Dicyclomine—Constipation—Pamidronate—osteoporosis	0.000814	0.00138	CcSEcCtD
Dicyclomine—Pain—Pamidronate—osteoporosis	0.000814	0.00138	CcSEcCtD
Dicyclomine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000812	0.00138	CcSEcCtD
Dicyclomine—Dizziness—Raloxifene—osteoporosis	0.000812	0.00138	CcSEcCtD
Dicyclomine—Tension—Estradiol—osteoporosis	0.000806	0.00137	CcSEcCtD
Dicyclomine—Vomiting—Estropipate—osteoporosis	0.000806	0.00137	CcSEcCtD
Dicyclomine—Dizziness—Ibandronate—osteoporosis	0.000804	0.00136	CcSEcCtD
Dicyclomine—Rash—Estropipate—osteoporosis	0.000799	0.00136	CcSEcCtD
Dicyclomine—Dermatitis—Estropipate—osteoporosis	0.000798	0.00136	CcSEcCtD
Dicyclomine—Anorexia—Conjugated Estrogens—osteoporosis	0.000798	0.00136	CcSEcCtD
Dicyclomine—Nervousness—Estradiol—osteoporosis	0.000798	0.00135	CcSEcCtD
Dicyclomine—Urticaria—Risedronate—osteoporosis	0.000796	0.00135	CcSEcCtD
Dicyclomine—Headache—Estropipate—osteoporosis	0.000794	0.00135	CcSEcCtD
Dicyclomine—Vomiting—Alendronate—osteoporosis	0.000794	0.00135	CcSEcCtD
Dicyclomine—Abdominal pain—Risedronate—osteoporosis	0.000792	0.00134	CcSEcCtD
Dicyclomine—Rash—Alendronate—osteoporosis	0.000787	0.00134	CcSEcCtD
Dicyclomine—Insomnia—Zoledronate—osteoporosis	0.000787	0.00134	CcSEcCtD
Dicyclomine—Dermatitis—Alendronate—osteoporosis	0.000786	0.00134	CcSEcCtD
Dicyclomine—Feeling abnormal—Pamidronate—osteoporosis	0.000785	0.00133	CcSEcCtD
Dicyclomine—Headache—Alendronate—osteoporosis	0.000782	0.00133	CcSEcCtD
Dicyclomine—Paraesthesia—Zoledronate—osteoporosis	0.000781	0.00133	CcSEcCtD
Dicyclomine—Vomiting—Raloxifene—osteoporosis	0.000781	0.00133	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000779	0.00132	CcSEcCtD
Dicyclomine—Dyspnoea—Zoledronate—osteoporosis	0.000775	0.00132	CcSEcCtD
Dicyclomine—Rash—Raloxifene—osteoporosis	0.000774	0.00131	CcSEcCtD
Dicyclomine—Dermatitis—Raloxifene—osteoporosis	0.000773	0.00131	CcSEcCtD
Dicyclomine—Somnolence—Zoledronate—osteoporosis	0.000773	0.00131	CcSEcCtD
Dicyclomine—Vomiting—Ibandronate—osteoporosis	0.000773	0.00131	CcSEcCtD
Dicyclomine—Headache—Raloxifene—osteoporosis	0.000769	0.00131	CcSEcCtD
Dicyclomine—Rash—Ibandronate—osteoporosis	0.000766	0.0013	CcSEcCtD
Dicyclomine—Dermatitis—Ibandronate—osteoporosis	0.000766	0.0013	CcSEcCtD
Dicyclomine—Dyspepsia—Zoledronate—osteoporosis	0.000766	0.0013	CcSEcCtD
Dicyclomine—Ill-defined disorder—Estradiol—osteoporosis	0.000762	0.00129	CcSEcCtD
Dicyclomine—Headache—Ibandronate—osteoporosis	0.000761	0.00129	CcSEcCtD
Dicyclomine—Insomnia—Conjugated Estrogens—osteoporosis	0.000757	0.00129	CcSEcCtD
Dicyclomine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000757	0.00129	CcSEcCtD
Dicyclomine—Vomiting—Calcitriol—osteoporosis	0.000756	0.00128	CcSEcCtD
Dicyclomine—Decreased appetite—Zoledronate—osteoporosis	0.000756	0.00128	CcSEcCtD
Dicyclomine—Agitation—Estradiol—osteoporosis	0.000755	0.00128	CcSEcCtD
Dicyclomine—Nausea—Estropipate—osteoporosis	0.000753	0.00128	CcSEcCtD
Dicyclomine—Abdominal pain—Pamidronate—osteoporosis	0.000753	0.00128	CcSEcCtD
Dicyclomine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000752	0.00128	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000751	0.00127	CcSEcCtD
Dicyclomine—Angioedema—Estradiol—osteoporosis	0.00075	0.00127	CcSEcCtD
Dicyclomine—Rash—Calcitriol—osteoporosis	0.00075	0.00127	CcSEcCtD
Dicyclomine—Fatigue—Zoledronate—osteoporosis	0.00075	0.00127	CcSEcCtD
Dicyclomine—Dermatitis—Calcitriol—osteoporosis	0.000749	0.00127	CcSEcCtD
Dicyclomine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000747	0.00127	CcSEcCtD
Dicyclomine—Headache—Calcitriol—osteoporosis	0.000745	0.00127	CcSEcCtD
Dicyclomine—Somnolence—Conjugated Estrogens—osteoporosis	0.000745	0.00126	CcSEcCtD
Dicyclomine—Pain—Zoledronate—osteoporosis	0.000744	0.00126	CcSEcCtD
Dicyclomine—Constipation—Zoledronate—osteoporosis	0.000744	0.00126	CcSEcCtD
Dicyclomine—Nausea—Alendronate—osteoporosis	0.000741	0.00126	CcSEcCtD
Dicyclomine—Malaise—Estradiol—osteoporosis	0.000741	0.00126	CcSEcCtD
Dicyclomine—Hypersensitivity—Risedronate—osteoporosis	0.000738	0.00125	CcSEcCtD
Dicyclomine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000737	0.00125	CcSEcCtD
Dicyclomine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000737	0.00125	CcSEcCtD
Dicyclomine—Syncope—Estradiol—osteoporosis	0.000736	0.00125	CcSEcCtD
Dicyclomine—Nausea—Raloxifene—osteoporosis	0.000729	0.00124	CcSEcCtD
Dicyclomine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000728	0.00124	CcSEcCtD
Dicyclomine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000727	0.00123	CcSEcCtD
Dicyclomine—Palpitations—Estradiol—osteoporosis	0.000726	0.00123	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000723	0.00123	CcSEcCtD
Dicyclomine—Fatigue—Conjugated Estrogens—osteoporosis	0.000722	0.00123	CcSEcCtD
Dicyclomine—Nausea—Ibandronate—osteoporosis	0.000722	0.00123	CcSEcCtD
Dicyclomine—Loss of consciousness—Estradiol—osteoporosis	0.000722	0.00123	CcSEcCtD
Dicyclomine—Asthenia—Risedronate—osteoporosis	0.000719	0.00122	CcSEcCtD
Dicyclomine—Feeling abnormal—Zoledronate—osteoporosis	0.000717	0.00122	CcSEcCtD
Dicyclomine—Pain—Conjugated Estrogens—osteoporosis	0.000716	0.00122	CcSEcCtD
Dicyclomine—Constipation—Conjugated Estrogens—osteoporosis	0.000716	0.00122	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000711	0.00121	CcSEcCtD
Dicyclomine—Hypertension—Estradiol—osteoporosis	0.000709	0.0012	CcSEcCtD
Dicyclomine—Pruritus—Risedronate—osteoporosis	0.000709	0.0012	CcSEcCtD
Dicyclomine—Nausea—Calcitriol—osteoporosis	0.000707	0.0012	CcSEcCtD
Dicyclomine—Hypersensitivity—Pamidronate—osteoporosis	0.000702	0.00119	CcSEcCtD
Dicyclomine—Urticaria—Zoledronate—osteoporosis	0.000691	0.00117	CcSEcCtD
Dicyclomine—Discomfort—Estradiol—osteoporosis	0.000691	0.00117	CcSEcCtD
Dicyclomine—Abdominal pain—Zoledronate—osteoporosis	0.000688	0.00117	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000685	0.00116	CcSEcCtD
Dicyclomine—Dry mouth—Estradiol—osteoporosis	0.000684	0.00116	CcSEcCtD
Dicyclomine—Asthenia—Pamidronate—osteoporosis	0.000683	0.00116	CcSEcCtD
Dicyclomine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000679	0.00115	CcSEcCtD
Dicyclomine—Confusional state—Estradiol—osteoporosis	0.000676	0.00115	CcSEcCtD
Dicyclomine—Pruritus—Pamidronate—osteoporosis	0.000674	0.00114	CcSEcCtD
Dicyclomine—Oedema—Estradiol—osteoporosis	0.00067	0.00114	CcSEcCtD
Dicyclomine—Anaphylactic shock—Estradiol—osteoporosis	0.00067	0.00114	CcSEcCtD
Dicyclomine—Urticaria—Conjugated Estrogens—osteoporosis	0.000665	0.00113	CcSEcCtD
Dicyclomine—Dizziness—Risedronate—osteoporosis	0.000662	0.00112	CcSEcCtD
Dicyclomine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000662	0.00112	CcSEcCtD
Dicyclomine—Shock—Estradiol—osteoporosis	0.000659	0.00112	CcSEcCtD
Dicyclomine—Nervous system disorder—Estradiol—osteoporosis	0.000657	0.00112	CcSEcCtD
Dicyclomine—Tachycardia—Estradiol—osteoporosis	0.000654	0.00111	CcSEcCtD
Dicyclomine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000653	0.00111	CcSEcCtD
Dicyclomine—Rash—Ethinyl Estradiol—osteoporosis	0.000648	0.0011	CcSEcCtD
Dicyclomine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000647	0.0011	CcSEcCtD
Dicyclomine—Headache—Ethinyl Estradiol—osteoporosis	0.000644	0.00109	CcSEcCtD
Dicyclomine—Hypersensitivity—Zoledronate—osteoporosis	0.000641	0.00109	CcSEcCtD
Dicyclomine—Vomiting—Risedronate—osteoporosis	0.000637	0.00108	CcSEcCtD
Dicyclomine—Rash—Risedronate—osteoporosis	0.000632	0.00107	CcSEcCtD
Dicyclomine—Dermatitis—Risedronate—osteoporosis	0.000631	0.00107	CcSEcCtD
Dicyclomine—Dizziness—Pamidronate—osteoporosis	0.00063	0.00107	CcSEcCtD
Dicyclomine—Headache—Risedronate—osteoporosis	0.000627	0.00107	CcSEcCtD
Dicyclomine—Asthenia—Zoledronate—osteoporosis	0.000624	0.00106	CcSEcCtD
Dicyclomine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000617	0.00105	CcSEcCtD
Dicyclomine—Pruritus—Zoledronate—osteoporosis	0.000615	0.00104	CcSEcCtD
Dicyclomine—Nausea—Ethinyl Estradiol—osteoporosis	0.00061	0.00104	CcSEcCtD
Dicyclomine—Insomnia—Estradiol—osteoporosis	0.000606	0.00103	CcSEcCtD
Dicyclomine—Vomiting—Pamidronate—osteoporosis	0.000605	0.00103	CcSEcCtD
Dicyclomine—Paraesthesia—Estradiol—osteoporosis	0.000602	0.00102	CcSEcCtD
Dicyclomine—Asthenia—Conjugated Estrogens—osteoporosis	0.000601	0.00102	CcSEcCtD
Dicyclomine—Rash—Pamidronate—osteoporosis	0.0006	0.00102	CcSEcCtD
Dicyclomine—Dermatitis—Pamidronate—osteoporosis	0.0006	0.00102	CcSEcCtD
Dicyclomine—Dyspnoea—Estradiol—osteoporosis	0.000598	0.00101	CcSEcCtD
Dicyclomine—Headache—Pamidronate—osteoporosis	0.000596	0.00101	CcSEcCtD
Dicyclomine—Somnolence—Estradiol—osteoporosis	0.000596	0.00101	CcSEcCtD
Dicyclomine—Nausea—Risedronate—osteoporosis	0.000595	0.00101	CcSEcCtD
Dicyclomine—Pruritus—Conjugated Estrogens—osteoporosis	0.000593	0.00101	CcSEcCtD
Dicyclomine—Dyspepsia—Estradiol—osteoporosis	0.00059	0.001	CcSEcCtD
Dicyclomine—Decreased appetite—Estradiol—osteoporosis	0.000583	0.000989	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000579	0.000982	CcSEcCtD
Dicyclomine—Fatigue—Estradiol—osteoporosis	0.000578	0.000981	CcSEcCtD
Dicyclomine—Dizziness—Zoledronate—osteoporosis	0.000575	0.000976	CcSEcCtD
Dicyclomine—Constipation—Estradiol—osteoporosis	0.000573	0.000973	CcSEcCtD
Dicyclomine—Pain—Estradiol—osteoporosis	0.000573	0.000973	CcSEcCtD
Dicyclomine—Nausea—Pamidronate—osteoporosis	0.000566	0.00096	CcSEcCtD
Dicyclomine—Dizziness—Conjugated Estrogens—osteoporosis	0.000554	0.00094	CcSEcCtD
Dicyclomine—Vomiting—Zoledronate—osteoporosis	0.000553	0.000939	CcSEcCtD
Dicyclomine—Feeling abnormal—Estradiol—osteoporosis	0.000552	0.000938	CcSEcCtD
Dicyclomine—Rash—Zoledronate—osteoporosis	0.000548	0.000931	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Estradiol—osteoporosis	0.000548	0.000931	CcSEcCtD
Dicyclomine—Dermatitis—Zoledronate—osteoporosis	0.000548	0.00093	CcSEcCtD
Dicyclomine—Headache—Zoledronate—osteoporosis	0.000545	0.000925	CcSEcCtD
Dicyclomine—Vomiting—Conjugated Estrogens—osteoporosis	0.000532	0.000904	CcSEcCtD
Dicyclomine—Urticaria—Estradiol—osteoporosis	0.000532	0.000904	CcSEcCtD
Dicyclomine—Abdominal pain—Estradiol—osteoporosis	0.00053	0.0009	CcSEcCtD
Dicyclomine—Rash—Conjugated Estrogens—osteoporosis	0.000528	0.000896	CcSEcCtD
Dicyclomine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000528	0.000896	CcSEcCtD
Dicyclomine—Headache—Conjugated Estrogens—osteoporosis	0.000525	0.000891	CcSEcCtD
Dicyclomine—Nausea—Zoledronate—osteoporosis	0.000517	0.000877	CcSEcCtD
Dicyclomine—Nausea—Conjugated Estrogens—osteoporosis	0.000497	0.000845	CcSEcCtD
Dicyclomine—Hypersensitivity—Estradiol—osteoporosis	0.000494	0.000838	CcSEcCtD
Dicyclomine—Asthenia—Estradiol—osteoporosis	0.000481	0.000816	CcSEcCtD
Dicyclomine—Pruritus—Estradiol—osteoporosis	0.000474	0.000805	CcSEcCtD
Dicyclomine—Dizziness—Estradiol—osteoporosis	0.000443	0.000752	CcSEcCtD
Dicyclomine—Vomiting—Estradiol—osteoporosis	0.000426	0.000724	CcSEcCtD
Dicyclomine—Rash—Estradiol—osteoporosis	0.000423	0.000717	CcSEcCtD
Dicyclomine—Dermatitis—Estradiol—osteoporosis	0.000422	0.000717	CcSEcCtD
Dicyclomine—Headache—Estradiol—osteoporosis	0.00042	0.000713	CcSEcCtD
Dicyclomine—Nausea—Estradiol—osteoporosis	0.000398	0.000676	CcSEcCtD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	2.09e-05	0.00391	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—PTH—osteoporosis	2.09e-05	0.00391	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—PTH—osteoporosis	2.08e-05	0.0039	CbGpPWpGaD
Dicyclomine—CYP1A1—Aryl Hydrocarbon Receptor—TNF—osteoporosis	2.07e-05	0.00387	CbGpPWpGaD
Dicyclomine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	2.07e-05	0.00387	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—PTH—osteoporosis	2.06e-05	0.00386	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—PTH1R—osteoporosis	2.04e-05	0.00382	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—CALCR—osteoporosis	2.04e-05	0.00382	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	2.04e-05	0.00381	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—CNR2—osteoporosis	2.04e-05	0.00381	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—PTH1R—osteoporosis	2.03e-05	0.00381	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—CALCR—osteoporosis	2.03e-05	0.00381	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—CNR2—osteoporosis	2.03e-05	0.0038	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—CALCR—osteoporosis	2.02e-05	0.00377	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—PTH1R—osteoporosis	2.02e-05	0.00377	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—CNR2—osteoporosis	2.01e-05	0.00376	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—WNT1—osteoporosis	1.91e-05	0.00358	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—WNT1—osteoporosis	1.91e-05	0.00357	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—WNT1—osteoporosis	1.89e-05	0.00353	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—MGLL—osteoporosis	1.79e-05	0.00334	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—MGLL—osteoporosis	1.78e-05	0.00333	CbGpPWpGaD
Dicyclomine—CHRM2—G alpha (i) signalling events—ADCY5—osteoporosis	1.77e-05	0.00331	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—MGLL—osteoporosis	1.76e-05	0.0033	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—IL6R—osteoporosis	1.76e-05	0.00329	CbGpPWpGaD
Dicyclomine—CHRM1—Circadian rythm related genes—LEP—osteoporosis	1.74e-05	0.00325	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—PTHLH—osteoporosis	1.73e-05	0.00324	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—PTHLH—osteoporosis	1.73e-05	0.00323	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—PTHLH—osteoporosis	1.71e-05	0.0032	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.63e-05	0.00305	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—MGLL—osteoporosis	1.62e-05	0.00303	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—MGLL—osteoporosis	1.62e-05	0.00302	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—MGLL—osteoporosis	1.6e-05	0.00299	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PKM—osteoporosis	1.59e-05	0.00297	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—FDPS—osteoporosis	1.59e-05	0.00297	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—CALCA—osteoporosis	1.52e-05	0.00285	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—CALCA—osteoporosis	1.52e-05	0.00284	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PGLS—osteoporosis	1.51e-05	0.00282	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—GPD2—osteoporosis	1.51e-05	0.00282	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—CALCA—osteoporosis	1.5e-05	0.00281	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.38e-05	0.00259	CbGpPWpGaD
Dicyclomine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	1.38e-05	0.00258	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PNP—osteoporosis	1.38e-05	0.00258	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—ATIC—osteoporosis	1.38e-05	0.00258	CbGpPWpGaD
Dicyclomine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	1.38e-05	0.00257	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—IL1B—osteoporosis	1.34e-05	0.0025	CbGpPWpGaD
Dicyclomine—CYP1A1—Biological oxidations—POMC—osteoporosis	1.34e-05	0.0025	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—SOST—osteoporosis	1.33e-05	0.00249	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—SOST—osteoporosis	1.33e-05	0.00249	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—SOST—osteoporosis	1.32e-05	0.00246	CbGpPWpGaD
Dicyclomine—CHRM2—G alpha (i) signalling events—POMC—osteoporosis	1.3e-05	0.00243	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—FDPS—osteoporosis	1.26e-05	0.00236	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PKM—osteoporosis	1.26e-05	0.00236	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CALCR—osteoporosis	1.21e-05	0.00226	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PTH1R—osteoporosis	1.21e-05	0.00226	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PTH1R—osteoporosis	1.2e-05	0.00225	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CALCR—osteoporosis	1.2e-05	0.00225	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GPD2—osteoporosis	1.2e-05	0.00224	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PGLS—osteoporosis	1.2e-05	0.00224	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CALCR—osteoporosis	1.19e-05	0.00223	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PTH1R—osteoporosis	1.19e-05	0.00223	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—PTH—osteoporosis	1.18e-05	0.00221	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—PTH—osteoporosis	1.18e-05	0.0022	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—OXCT1—osteoporosis	1.17e-05	0.00219	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CA2—osteoporosis	1.17e-05	0.00219	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—PTH—osteoporosis	1.17e-05	0.00218	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—CNR2—osteoporosis	1.15e-05	0.00215	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—CNR2—osteoporosis	1.15e-05	0.00215	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—MGLL—osteoporosis	1.14e-05	0.00214	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—CNR2—osteoporosis	1.14e-05	0.00212	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—ATIC—osteoporosis	1.09e-05	0.00205	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PNP—osteoporosis	1.09e-05	0.00205	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—PTH—osteoporosis	1.07e-05	0.00201	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—PTH—osteoporosis	1.07e-05	0.002	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—PTH—osteoporosis	1.06e-05	0.00198	CbGpPWpGaD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	1.05e-05	0.00196	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—CNR2—osteoporosis	1.04e-05	0.00195	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	1.04e-05	0.00195	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—CNR2—osteoporosis	1.04e-05	0.00195	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	1.03e-05	0.00193	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—CNR2—osteoporosis	1.03e-05	0.00193	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—WNT1—osteoporosis	9.82e-06	0.00184	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—WNT1—osteoporosis	9.79e-06	0.00183	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—PTHLH—osteoporosis	9.78e-06	0.00183	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—PTHLH—osteoporosis	9.75e-06	0.00182	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—TNF—osteoporosis	9.72e-06	0.00182	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—IDH2—osteoporosis	9.71e-06	0.00182	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—WNT1—osteoporosis	9.7e-06	0.00181	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—PTHLH—osteoporosis	9.66e-06	0.00181	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MGLL—osteoporosis	9.58e-06	0.00179	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MGLL—osteoporosis	9.55e-06	0.00179	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MGLL—osteoporosis	9.46e-06	0.00177	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—LRP5—osteoporosis	9.35e-06	0.00175	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—LRP5—osteoporosis	9.32e-06	0.00174	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—OXCT1—osteoporosis	9.31e-06	0.00174	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CA2—osteoporosis	9.31e-06	0.00174	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—LRP5—osteoporosis	9.23e-06	0.00173	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CYP27A1—osteoporosis	9.13e-06	0.00171	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—MGLL—osteoporosis	9.07e-06	0.0017	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—LRP6—osteoporosis	8.94e-06	0.00167	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—LRP6—osteoporosis	8.91e-06	0.00167	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—PTHLH—osteoporosis	8.89e-06	0.00166	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—ACP5—osteoporosis	8.88e-06	0.00166	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—PTHLH—osteoporosis	8.86e-06	0.00166	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—LRP6—osteoporosis	8.83e-06	0.00165	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—PTHLH—osteoporosis	8.77e-06	0.00164	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—CALCA—osteoporosis	8.61e-06	0.00161	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—CALCA—osteoporosis	8.59e-06	0.00161	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	8.55e-06	0.0016	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—CALCA—osteoporosis	8.5e-06	0.00159	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—TPI1—osteoporosis	8.26e-06	0.00154	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—POMC—osteoporosis	7.98e-06	0.00149	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—POMC—osteoporosis	7.95e-06	0.00149	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—POMC—osteoporosis	7.87e-06	0.00147	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—IL6—osteoporosis	7.84e-06	0.00147	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—CALCA—osteoporosis	7.82e-06	0.00146	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—CALCA—osteoporosis	7.8e-06	0.00146	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—P4HB—osteoporosis	7.76e-06	0.00145	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—CALCA—osteoporosis	7.72e-06	0.00144	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—IDH2—osteoporosis	7.71e-06	0.00144	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—GAPDH—osteoporosis	7.62e-06	0.00143	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—TLN1—osteoporosis	7.55e-06	0.00141	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—TLN1—osteoporosis	7.53e-06	0.00141	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—TLN1—osteoporosis	7.45e-06	0.00139	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—RAP1A—osteoporosis	7.42e-06	0.00139	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CYP27A1—osteoporosis	7.25e-06	0.00136	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—ACP5—osteoporosis	7.06e-06	0.00132	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	6.97e-06	0.0013	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—TPI1—osteoporosis	6.56e-06	0.00123	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—P4HB—osteoporosis	6.51e-06	0.00122	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—P4HB—osteoporosis	6.49e-06	0.00121	CbGpPWpGaD
Dicyclomine—CHRM1—Circadian rythm related genes—IL6—osteoporosis	6.49e-06	0.00121	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—P4HB—osteoporosis	6.43e-06	0.0012	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PTH—osteoporosis	6.33e-06	0.00118	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PTH—osteoporosis	6.31e-06	0.00118	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PTH—osteoporosis	6.25e-06	0.00117	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—RAP1A—osteoporosis	6.23e-06	0.00116	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—RAP1A—osteoporosis	6.21e-06	0.00116	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CNR2—osteoporosis	6.17e-06	0.00115	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—P4HB—osteoporosis	6.17e-06	0.00115	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CNR2—osteoporosis	6.15e-06	0.00115	CbGpPWpGaD
Dicyclomine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	6.15e-06	0.00115	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—RAP1A—osteoporosis	6.15e-06	0.00115	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—ADCY5—osteoporosis	6.13e-06	0.00115	CbGpPWpGaD
Dicyclomine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	6.13e-06	0.00115	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—ADCY5—osteoporosis	6.11e-06	0.00114	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CNR2—osteoporosis	6.09e-06	0.00114	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NFATC1—osteoporosis	6.07e-06	0.00114	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NFATC1—osteoporosis	6.05e-06	0.00113	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GAPDH—osteoporosis	6.05e-06	0.00113	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—ADCY5—osteoporosis	6.05e-06	0.00113	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—DKK1—osteoporosis	6.03e-06	0.00113	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—DKK1—osteoporosis	6.01e-06	0.00112	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—ENO1—osteoporosis	6e-06	0.00112	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NFATC1—osteoporosis	5.99e-06	0.00112	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—DKK1—osteoporosis	5.95e-06	0.00111	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PSMA2—osteoporosis	5.91e-06	0.00111	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PSMA5—osteoporosis	5.91e-06	0.00111	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—RAP1A—osteoporosis	5.9e-06	0.0011	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—WNT1—osteoporosis	5.8e-06	0.00109	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—WNT1—osteoporosis	5.79e-06	0.00108	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—WNT1—osteoporosis	5.73e-06	0.00107	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—FGA—osteoporosis	5.65e-06	0.00106	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—FGA—osteoporosis	5.63e-06	0.00105	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—FGA—osteoporosis	5.57e-06	0.00104	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—ADCY5—osteoporosis	5.56e-06	0.00104	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—ADCY5—osteoporosis	5.55e-06	0.00104	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—ADCY5—osteoporosis	5.49e-06	0.00103	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PTHLH—osteoporosis	5.25e-06	0.000982	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—BMP2—osteoporosis	5.25e-06	0.000982	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—BMP2—osteoporosis	5.23e-06	0.000979	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PTHLH—osteoporosis	5.23e-06	0.000979	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PTHLH—osteoporosis	5.18e-06	0.000969	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—BMP2—osteoporosis	5.18e-06	0.000969	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	5.14e-06	0.000962	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—FGB—osteoporosis	5.14e-06	0.000961	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—FGB—osteoporosis	5.12e-06	0.000958	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—FGB—osteoporosis	5.07e-06	0.000948	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PSMA2—osteoporosis	4.96e-06	0.000927	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PSMA5—osteoporosis	4.96e-06	0.000927	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PSMA2—osteoporosis	4.94e-06	0.000925	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PSMA5—osteoporosis	4.94e-06	0.000925	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PSMA2—osteoporosis	4.89e-06	0.000916	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PSMA5—osteoporosis	4.89e-06	0.000916	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CYP19A1—osteoporosis	4.8e-06	0.000897	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—ENO1—osteoporosis	4.77e-06	0.000891	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PSMA5—osteoporosis	4.7e-06	0.000878	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PSMA2—osteoporosis	4.7e-06	0.000878	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CALCA—osteoporosis	4.62e-06	0.000864	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CALCA—osteoporosis	4.61e-06	0.000862	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CALCA—osteoporosis	4.56e-06	0.000853	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—POMC—osteoporosis	4.51e-06	0.000843	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—POMC—osteoporosis	4.49e-06	0.00084	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—POMC—osteoporosis	4.45e-06	0.000832	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—KL—osteoporosis	4.2e-06	0.000785	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—KL—osteoporosis	4.18e-06	0.000782	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—KL—osteoporosis	4.14e-06	0.000775	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—POMC—osteoporosis	4.09e-06	0.000766	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—POMC—osteoporosis	4.08e-06	0.000763	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—POMC—osteoporosis	4.04e-06	0.000756	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—IL6R—osteoporosis	3.99e-06	0.000747	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—IL6R—osteoporosis	3.98e-06	0.000744	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—IL6R—osteoporosis	3.94e-06	0.000737	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—ADCY5—osteoporosis	3.92e-06	0.000733	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—GPX1—osteoporosis	3.91e-06	0.00073	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CYP19A1—osteoporosis	3.81e-06	0.000713	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—MTHFR—osteoporosis	3.6e-06	0.000674	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ADCY5—osteoporosis	3.29e-06	0.000615	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ADCY5—osteoporosis	3.28e-06	0.000613	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ADCY5—osteoporosis	3.24e-06	0.000607	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—SPP1—osteoporosis	3.18e-06	0.000595	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—SPP1—osteoporosis	3.17e-06	0.000593	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—SPP1—osteoporosis	3.14e-06	0.000587	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—ADCY5—osteoporosis	3.11e-06	0.000582	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GPX1—osteoporosis	3.1e-06	0.00058	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—POMC—osteoporosis	2.88e-06	0.000539	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IRS2—osteoporosis	2.88e-06	0.000538	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IRS2—osteoporosis	2.87e-06	0.000536	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—MTHFR—osteoporosis	2.86e-06	0.000535	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IRS2—osteoporosis	2.84e-06	0.000531	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—LEP—osteoporosis	2.81e-06	0.000526	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—LEP—osteoporosis	2.81e-06	0.000525	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—LEP—osteoporosis	2.78e-06	0.00052	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ESR1—osteoporosis	2.69e-06	0.000503	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ESR1—osteoporosis	2.68e-06	0.000501	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ESR1—osteoporosis	2.65e-06	0.000496	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IRS1—osteoporosis	2.51e-06	0.00047	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IRS1—osteoporosis	2.5e-06	0.000468	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IRS1—osteoporosis	2.48e-06	0.000464	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—POMC—osteoporosis	2.42e-06	0.000452	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—POMC—osteoporosis	2.41e-06	0.000451	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—POMC—osteoporosis	2.39e-06	0.000446	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IL6R—osteoporosis	2.36e-06	0.000441	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IL6R—osteoporosis	2.35e-06	0.00044	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IL6R—osteoporosis	2.33e-06	0.000435	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IGF1—osteoporosis	2.33e-06	0.000435	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IGF1—osteoporosis	2.32e-06	0.000434	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IGF1—osteoporosis	2.3e-06	0.000429	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—POMC—osteoporosis	2.29e-06	0.000428	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—IL6—osteoporosis	1.78e-06	0.000333	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—IL6—osteoporosis	1.77e-06	0.000332	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—IL6—osteoporosis	1.76e-06	0.000328	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MYC—osteoporosis	1.4e-06	0.000261	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—TGFB1—osteoporosis	1.39e-06	0.000261	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MYC—osteoporosis	1.39e-06	0.000261	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—TGFB1—osteoporosis	1.39e-06	0.00026	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MYC—osteoporosis	1.38e-06	0.000258	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—TGFB1—osteoporosis	1.38e-06	0.000257	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IL6—osteoporosis	1.05e-06	0.000197	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IL6—osteoporosis	1.05e-06	0.000196	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IL6—osteoporosis	1.04e-06	0.000194	CbGpPWpGaD
